The Clopidogrel Dilemma in Thromboprophylaxis Following Total Joint Arthroplasty: Commentary on an article by Sahil S. Telang, BS, et al.: "Postoperative Clopidogrel Thromboprophylaxis in TJA. Increased Risk of Transfusion but Similar Venous Thromboembolic Risk Compared with Aspirin"

Beksaç B

Open at JBJS Am ↗View on PubMed ↗

Journal

J Bone Joint Surg Am

PMID

42159561

DOI

10.2106/JBJS.25.01399

Abstract

No abstract available for this record.

Open at JBJS Am →View on PubMed →

Preview Vancouver citation

Beksaç B. The Clopidogrel Dilemma in Thromboprophylaxis Following Total Joint Arthroplasty: Commentary on an article by Sahil S. Telang, BS, et al.: "Postoperative Clopidogrel Thromboprophylaxis in TJA. Increased Risk of Transfusion but Similar Venous Thromboembolic Risk Compared with Aspirin". J Bone Joint Surg Am. 2026 May. doi:10.2106/JBJS.25.01399. PMID: 42159561.

Metadata sourced from the U.S. National Library of Medicine (PubMed). OrthoGlobe curates but does not host the full-text article.

The Clopidogrel Dilemma in Thromboprophylaxis Following Total Joint Arthroplasty: Commentary on an article by Sahil S. Telang, BS, et al.: "Postoperative Clopidogrel Thromboprophylaxis in TJA. Increased Risk of Transfusion but Similar Venous Thromboembolic Risk Compared with Aspirin" — OrthoGlobe